Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Transanal Endoscopic Microsurgery (TEM) After Radiochemotherapy for Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine and CAPOX in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE3